Optiver Holding’s Medifast MED Stock Holding History

Optiver Holding’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-112	Closed	-$1.14K	–	2962
2026 Q1	$1.14K	Sell	112 -64	-36%	-$690	﹤0.01%	2034
2025 Q4	$1.88K	Hold	176	–	–	﹤0.01%	2048
2025 Q3	$2.41K	Buy	+176	New	+$2.46K	﹤0.01%	2309

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Optiver Holding's MED Position: Q2 2026 in Review

Optiver Holding sold out of Medifast (MED) in Q2 2026, closing a stake of 112 shares — an estimated $1.14K sold.

Optiver Holding first reported a position in MED in Q3 2025 and held it in 3 quarters. The position peaked at $2.41K in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Optiver Holding reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 112 Medifast shares in Q2 2026, an estimated $1.14K.
Optiver Holding first reported a position in Medifast in Q3 2025 and held it in 3 quarters.
Optiver Holding's Medifast position peaked at $2.41K in Q3 2025.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.